Jazz Pharmaceuticals: RBC cuts target price to $296 from $299
JAZZ•RBC cut its target price for Jazz Pharmaceuticals to $296 from $299.
Related News
MasTec Inc.: Stifel cuts target price to $305 from $376
MTZ•
Margaret Qualley drawn to 'emotional ride' of romantic drama 'Love of Your Life'
AMZN•
Century Communities acquires HistoryMaker Homes, expands Dallas-Fort Worth presence
CCS•
ServiceTitan unit FieldRoutes rolls out next phase of product innovation at Ignite 2026
TTAN•
EV maker Polestar logs slightly higher quarterly sales as US ban looms
PSNY•